E16.1

Other hypoglycemia

E16.1 is a specific clinical classification for non-diabetic hypoglycemia not specified elsewhere. It encompasses various forms of low blood glucose levels (typically below 70 mg/dL in non-diabetics) that are not the result of exogenous insulin or oral hypoglycemic agents used in diabetes management. This code covers conditions such as reactive hypoglycemia (postprandial hypoglycemia), which occurs after eating; hyperinsulinism not otherwise specified; and other metabolic or functional hypoglycemic states. Clinically, it is identified using Whipple's triad: clinical signs and symptoms of hypoglycemia, a low plasma glucose concentration, and the resolution of symptoms once glucose levels are elevated. This diagnosis is essential for patients presenting with neuroglycopenic or autonomic symptoms in the absence of a diabetes mellitus diagnosis, requiring investigations into endogenous insulin production, enzymatic defects, or post-surgical complications like dumping syndrome.

Clinical Symptoms

Diaphoresis (excessive sweating)
Tachycardia or palpitations
Tremors or shakiness
Intense hunger (polyphagia)
Anxiety and nervousness
Confusion or cognitive impairment
Visual disturbances (blurred vision)
Dizziness or lightheadedness
Irritability and behavioral changes
Paresthesia (tingling sensations, often perioral)
Seizures in severe cases
Loss of consciousness
Fatigue or lethargy

Common Causes

Endogenous hyperinsulinism (e.g., insulinoma or islet cell hyperplasia)
Noninsulinoma pancreatogenous hypoglycemia syndrome (NIPHS)
Post-gastric bypass hypoglycemia (late dumping syndrome)
Severe liver disease (impaired gluconeogenesis/glycogenolysis)
Adrenal insufficiency (Addison's disease)
Hormone deficiencies (Growth hormone or cortisol deficiency)
Alcohol-induced hypoglycemia (fasting state)
Critical illness (severe sepsis or renal failure)
Non-islet cell tumor hypoglycemia (NICTH)
Reactive hypoglycemia (post-meal insulin spike)

Documentation & Coding Tips

Distinguish between fasting and postprandial states to accurately categorize hypoglycemia under the E16 code set.

Example: Patient with history of gastric bypass presents with neuroglycopenic symptoms occurring 2 hours after high-carbohydrate meals. Blood glucose documented at 52 mg/dL with resolution of symptoms upon administration of oral glucose, confirming Whipple's triad. Diagnosis: Reactive hypoglycemia (E16.1) following Roux-en-Y gastric bypass. Condition is chronic and managed with dietary modification.

Billing Focus: Documentation of the temporal relationship between food intake and symptoms supports the specificity of E16.1 over E16.2.

Include clinical evidence of Whipple's triad to support the medical necessity of diagnostic workups for hypoglycemia.

Example: Evaluation for persistent fasting hypoglycemia. Observed plasma glucose 45 mg/dL accompanied by diaphoresis and confusion. Symptoms resolved immediately following intravenous D50 administration. Plan for 72-hour fast to rule out insulinoma or other endogenous hyperinsulinism causes. Diagnosis: Other hypoglycemia (E16.1).

Billing Focus: Clear documentation of symptomatic relief with glucose administration validates the diagnostic criteria for other hypoglycemia.

Specify the underlying etiology when known, such as non-insulinoma pancreatogenous hypoglycemia syndrome (NIPHS) or dumping syndrome.

Example: Patient reports recurrent episodes of symptomatic hypoglycemia. Workup reveals postprandial hyperinsulinism without evidence of insulinoma on imaging. Diagnosis: Non-insulinoma pancreatogenous hypoglycemia syndrome, coded as other hypoglycemia (E16.1). Management includes acarbose to slow carbohydrate absorption.

Billing Focus: Specifying the clinical syndrome associated with E16.1 ensures the code choice reflects the highest level of clinical certainty.

Differentiate between drug-induced and non-drug-induced hypoglycemia for accurate ICD-10 selection.

Example: Hypoglycemic event in a non-diabetic patient determined not to be caused by exogenous medications or accidental ingestion of secretagogues. Laboratory findings show suppressed insulin and C-peptide during the event, suggesting non-islet cell tumor hypoglycemia (NICTH). Diagnosis: Other hypoglycemia (E16.1).

Billing Focus: Excluding drug-induced causes (E16.0) is necessary to justify the use of E16.1.

Document the frequency and severity of episodes to justify intensive management or use of continuous glucose monitoring (CGM).

Example: Patient experiences 3-4 weekly episodes of symptomatic hypoglycemia (E16.1) despite adherence to a low-glycemic diet. Prescribing a professional CGM to identify asymptomatic nocturnal dips. Condition is persistent and requires ongoing endocrinology surveillance.

Billing Focus: Frequency of episodes supports the medical necessity for higher-level E/M codes and diagnostic procedures.

Relevant CPT Codes

99214 - Office or other outpatient visit for the evaluation and management of an established patient, which requires a moderate level of medical decision making. When using total time on the date of the encounter for code selection, 30-39 minutes must be met or exceeded.
Evaluating and managing E16.1 often involves reviewing glucose logs and adjusting complex diets, qualifying as moderate MDM.
99215 - Office or other outpatient visit for the evaluation and management of an established patient, which requires a high level of medical decision making. When using total time on the date of the encounter for code selection, 40-54 minutes must be met or exceeded.
High MDM is required when E16.1 leads to severe neuroglycopenia or requires coordination for suspected insulinoma.
99204 - Office or other outpatient visit for the evaluation and management of a new patient, which requires a moderate level of medical decision making. When using total time on the date of the encounter for code selection, 45-59 minutes must be met or exceeded.
Moderate MDM is typical for the initial diagnostic framing of non-diabetic hypoglycemia.
82947 - Glucose; quantitative, blood (except reagent strip)
Essential for confirming hypoglycemia and fulfilling Whipple's triad.
83525 - Insulin; total
Used to differentiate between endogenous hyperinsulinism and other causes of E16.1.
84681 - C-peptide
Distinguishes between endogenous insulin production and exogenous insulin administration.
82951 - Glucose; tolerance test (GTT), 3 specimens (includes glucose)
Used to provoke and document hypoglycemia following a glucose load.
95250 - Ambulatory continuous glucose monitoring of interstitial tissue fluid via a subcutaneous sensor for a minimum of 72 hours; physician or other qualified health care professional provided equipment, sensor placement, hook-up, calibration of monitor, patient training, removal of sensor, and printout of recording
Used to capture real-world hypoglycemic events in patients with suspected E16.1.
74177 - Computed tomography, abdomen and pelvis; with contrast material(s)
Used in the workup of fasting hypoglycemia (E16.1) to find anatomical causes.
99213 - Office or other outpatient visit for the evaluation and management of an established patient, which requires a low level of medical decision making. When using total time on the date of the encounter for code selection, 20-29 minutes must be met or exceeded.
Used for stable patients requiring minimal changes to their dietary management plan.